Coronavirus updates: US reports nearly 300,000 new cases in all-time high
A staggering 299,087 new cases were confirmed over the past 24 hours.
A pandemic of the novel coronavirus has now infected more than 84.6 million people worldwide and killed over 1.8 million of them, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.
Latest headlines:
India approves 2 COVID-19 vaccines for emergency use
India's drugs regulator granted an emergency use authorization for two COVID-19 vaccines on Sunday.
One is the British-developed Oxford/AstraZeneca vaccine, which is being produced locally by the Serum Institute of India, and the other, Covaxin, was developed by Indian biotechnology company Bharat Biotech. Both vaccines, which will be administered in two doses, "are being approved for restricted use in emergency situations," Drugs Controller General of India, Dr. Venugopal G Somani, said during a press conference Sunday.
Somani said the decision to approve the vaccines was made after "careful examination," by the Central Drugs Standard Control Organization, the national regulatory body in India for pharmaceuticals and medical devices.
Indian Prime Minister Narendra Modi welcomed the approval, calling it a "defining moment."
"It is a matter of pride that the two vaccines that have been approved for emergency use are both made in India," Modi wrote on his official Twitter account Sunday. "This reflects the will of our scientific community to fulfill the dream of a self-reliant India."
The first phase of India's mass immunization plan aims to vaccinate 300 million people by August, including health care workers, police officers and anyone deemed vulnerable due to their age or health conditions.
The country of nearly 1.4 billion people has the second-highest tally of diagnosed COVID-19 cases in the world, behind only the United States. Since the start of the pandemic, India's Ministry of Health and Family Welfare has reported more than 10.3 million confirmed cases, including at least 149,435 deaths.
England's health agency says it does not recommend mixing COVID-19 vaccines
Public Health England does not recommend mixing COVID-19 vaccines from different suppliers, according to the agency's head of immunizations, Dr. Mary Ramsay.
"We do not recommend mixing the COVID-19 vaccines -- if your first dose is the Pfizer vaccine you should not be given the AstraZeneca vaccine for your second dose and vice versa," Ramsay said in a statement Saturday. "There may be extremely rare occasions where the same vaccine is not available, or where it is not known what vaccine the patient received. Every effort should be made to give them the same vaccine, but where this is not possible it is better to give a second dose of another vaccine than not at all."
The clarification comes amid questions over the British government's updated guidance on COVID-19 vaccines, which now says that if individuals who received the first shot go to an immunization site where that same vaccine is not available for a second shot, or if the first vaccine received is unknown, "it is reasonable to offer one dose of the locally available product to complete the schedule."
"This option is preferred if the individual is likely to be at immediate high risk or is considered unlikely to attend again," the guidance adds.
The guidance, which was updated Thursday, also notes that "there is no evidence on the interchangeability of the COVID-19 vaccines although studies are underway," and thus "every effort should be made to determine which vaccine the individual received and to complete with the same vaccine."
Next week, the United Kingdom is set to begin distribution of a COVID-19 vaccine developed by England's University of Oxford and manufactured by British-Swedish pharmaceutical giant AstraZeneca, after the drug was approved Wednesday for emergency supply. Another COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech was approved in the U.K. on Dec. 2 and rollout began a week later.
ABC News' Zoe Magee contributed to this report.
New Zealand to require travelers from US, UK to test negative before departing
New Zealand will require all travelers from the United States and the United Kingdom to test negative for COVID-19 before departing for the country.
The new rule, which will come into effect Jan. 15, is in addition to a requirement that was implemented from Dec. 31 for passengers arriving from both nations to be tested within 24 hours of their arrival in New Zealand and to remain isolated until a test result is available. The U.S. and the U.K. are two of the hardest hit countries in the coronavirus pandemic.
The latest measures "are extra precautionary steps which provide another layer of protection for New Zealand from COVID-19," New Zealand's Ministry of Health said in a statement Sunday.
New Zealand, an island nation of 5 million people in the southwestern Pacific Ocean, has reported at least 2,181 confirmed cases of COVID-19 since the start of the pandemic, including 25 deaths, according to the latest data from the health ministry.
US death toll tops 350,000
The U.S. death toll from the coronavirus pandemic has surpassed 350,000.
The number of people who have died from COVID-19 in the United States was 350,186 as of early Sunday morning, according to a real-time count kept by Johns Hopkins University.
The country has by far the highest death toll from the disease.
COVID vaccines given to general public in Kentucky a 'mistake,' governor says
Kentucky Gov. Andy Beshear spoke out Monday after Walgreens stores in Louisville and Lexington, Kentucky, gave COVID-19 vaccines to members of the general public.
Beshear said at a press conference that last week, the pharmacies were left with extra doses of the vaccine after administering it to long-term care facilities, so, they offered the leftover doses to average citizens. This, the governor said, does not follow government protocol, as the vaccine is not yet being given to the general public.
"I don't think that this was intentional, and we have to understand that in an undertaking this massive that mistakes are going to happen," Beshear said. "I believe that here a mistake happened in the thawing, but the reaction wasn't what it should've been."
In a statement, Walgreens said that per the Centers for Disease Control and Prevention's guidance, Pfizer’s COVID-19 vaccine can be at refrigerated temperatures for only five days, so, to avoid wasting doses of the valuable vaccine after giving it to at-risk adults in long-term care facilities, they used the leftover doses they had on residents.
The doses were offered to local first responders, Walgreens pharmacy and store team members and residents of the community, many of whom were over age 65, Walgreens said.
"These measures were taken to ensure every dose of a limited vaccine supply was used to protect patients and communities," the company added. "We will utilize excess vaccine inventory in priority patient populations and continue to work closely with state and federal health agencies in our efforts to vaccinate residents in long-term care facilities and ensure requested doses meet their needs."